Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 7, 2012; 18(25): 3215-3222
Published online Jul 7, 2012. doi: 10.3748/wjg.v18.i25.3215
Published online Jul 7, 2012. doi: 10.3748/wjg.v18.i25.3215
Table 4 Analysis of treatment response according to standardized uptake value ratio by barcelona clinic liver cancer score staging
| Treatment response | |||||||
| BCLC stage | Tsuvmax/Lsuvmean | CR | PR | SD | PD | Total | P value |
| A | < 1.90 | 18 | 3 | 0 | 0 | 21 | 1.0 |
| (n = 26) | ≥ 1.90 | 4 | 1 | 0 | 0 | 5 | |
| B | < 1.90 | 5 | 3 | 2 | 3 | 13 | 0.048 |
| (n = 20) | ≥ 1.90 | 0 | 4 | 3 | 0 | 7 | |
| C | < 1.90 | 2 | 4 | 4 | 0 | 10 | 0.000 |
| (n = 37) | ≥ 1.90 | 0 | 1 | 11 | 15 | 27 | |
| Total | 29 | 16 | 20 | 18 | 83 | ||
- Citation: Song MJ, Bae SH, Yoo IR, Park CH, Jang JW, Chun HJ, Choi BG, Lee HG, Choi JY, Yoon SK. Predictive value of 18F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma. World J Gastroenterol 2012; 18(25): 3215-3222
- URL: https://www.wjgnet.com/1007-9327/full/v18/i25/3215.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i25.3215